EGFR and non-small cell lung carcinoma: Given their strong immunogenicity for human T cells, the identified T cell epitopes could provide a novel and promising immunotherapeutic approach for prevention and/or treatment of the secondary EGFR T790M mutation in NSCLC patients treated with EGFR-TKIs.